Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: Accuracy and interobserver agreement

Histopathology

Volumn 66, Issue 7, 2015, Pages 922-938

  Yeh, Yi Chen ^a,b,c   Nitadori, Jun Ichi ^a,d   Kadota, Kyuichi ^a   Yoshizawa, Akihiko ^a   Rekhtman, Natasha ^a   Moreira, Andre L ^a   Sima, Camelia S ^a   Rusch, Valerie W ^a   Adusumilli, Prasad S ^a   Travis, William D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Frozen sections; Histological subtype; Invasion; Limited resection; Lung adenocarcinoma; Micropapillary; Solid

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOG RANK TEST; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; POSITRON; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAMPLING ERROR; ADENOCARCINOMA; AGED; LUNG TUMOR; MIDDLE AGED; OBSERVER VARIATION; PATHOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADENOCARCINOMA OF LUNG; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FROZEN SECTIONS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OBSERVER VARIATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84929134747     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12468     Document Type: Article

References (49)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011; 61; 69-90.
2. Devesa SS, Bray F, Vizcaino AP, Parkin DM. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int. J. Cancer 2005; 117; 294-299.
3. Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: geographical distribution and secular trends. J. Thorac. Oncol. 2008; 3; 819-831.
4. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011; 365; 395-409.
5. Fukui T, Sakakura N, Mori S et al. Controversy about small peripheral lung adenocarcinomas: how should we manage them? J. Thorac. Oncol. 2007; 2; 546-552.
6. Blasberg JD, Pass HI, Donington JS. Sublobar resection: a movement from the lung cancer study group. J. Thorac. Oncol. 2010; 5; 1583-1593.
7. Travis WD, Brambilla E, Noguchi M et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 2011; 6; 244-285.
8. Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA. Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J. Thorac. Oncol. 2011; 6; 1496-1504.
9. Yoshizawa A, Motoi N, Riely GJ et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod. Pathol. 2011; 24; 653-664.
10. Yoshizawa A, Sumiyoshi S, Sonobe M et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J. Thorac. Oncol. 2013; 8; 52-61.
11. Warth A, Muley T, Meister M et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J. Clin. Oncol. 2012; 30; 1438-1446.
12. Amin MB, Tamboli P, Merchant SH et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am. J. Surg. Pathol. 2002; 26; 358-364.
13. Miyoshi T, Satoh Y, Okumura S et al. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis. Am. J. Surg. Pathol. 2003; 27; 101-109.
14. Makimoto Y, Nabeshima K, Iwasaki H et al. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (
15. Kawakami T, Nabeshima K, Makimoto Y et al. Micropapillary pattern and grade of stromal invasion in PT1 adenocarcinoma of the lung: usefulness as prognostic factors. Mod. Pathol. 2007; 20; 514-521.
16. Tsutsumida H, Nomoto M, Goto M et al. A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis. Mod. Pathol. 2007; 20; 638-647.
17. Kamiya K, Hayashi Y, Douguchi J et al. Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod. Pathol. 2008; 21; 992-1001.
18. Sanchez-Mora N, Presmanes MC, Monroy V et al. Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series. Hum. Pathol. 2008; 39; 324-330.
19. Zhang J, Liang Z, Gao J, Luo Y, Liu T. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis. Histopathology 2011; 59; 1204-1214.
20. Riquet M, Foucault C, Berna P, Assouad J, Dujon A, Danel C. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann. Thorac. Surg. 2006; 81; 1988-1995.
21. Barletta JA, Yeap BY, Chirieac LR. Prognostic significance of grading in lung adenocarcinoma. Cancer 2010; 116; 659-669.
22. Ohtaki Y, Yoshida J, Ishii G et al. Prognostic significance of a solid component in pulmonary adenocarcinoma. Ann. Thorac. Surg. 2011; 91; 1051-1057.
23. Nitadori J-i, Bograd AJ, Kadota K et al. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2 cm or smaller. J. Natl Cancer Inst. 2013; 105; 1212-1220.
24. Kadota K, Suzuki K, Kachala SS et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod. Pathol. 2012; 25; 1117-1127.
25. Myung JK, Choe G, Chung DH et al. A simple inflation method for frozen section diagnosis of minute precancerous lesions of the lung. Lung Cancer 2008; 59; 198-202.
26. Xu X, Chung JH, Jheon S et al. The accuracy of frozen section diagnosis of pulmonary nodules: evaluation of inflation method during intraoperative pathology consultation with cryosection. J. Thorac. Oncol. 2010; 5; 39-44.
27. Motoi N, Szoke J, Riely GJ et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am. J. Surg. Pathol. 2008; 32; 810-827.
28. Donington J, Ferguson M, Mazzone P et al. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest 2012; 142; 1620-1635.
29. Kundel HL, Polansky M. Measurement of observer agreement. Radiology 2003; 228; 303-308.
30. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann. Thorac. Surg. 1995; 60; 615-622 discussion 622-613.
31. El-Sherif A, Gooding WE, Santos R et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann. Thorac. Surg. 2006; 82; 408-415 discussion 415-406.
32. Wolf AS, Richards WG, Jaklitsch MT et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann. Thorac. Surg. 2011; 92; 1819-1823 discussion 1824-1815.
33. Yamato Y, Tsuchida M, Watanabe T et al. Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung. Ann. Thorac. Surg. 2001; 71; 971-974.
34. Nakamura H, Saji H, Ogata A, Saijo T, Okada S, Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004; 44; 61-68.
35. Watanabe T, Okada A, Imakiire T, Koike T, Hirono T. Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration. Jpn. J. Thorac. Cardiovasc. Surg. 2005; 53; 29-35.
36. Yoshida J, Nagai K, Yokose T et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J. Thorac. Cardiovasc. Surg. 2005; 129; 991-996.
37. Koike T, Togashi K, Shirato T et al. Limited resection for noninvasive bronchioloalveolar carcinoma diagnosed by intraoperative pathologic examination. Ann. Thorac. Surg. 2009; 88; 1106-1111.
38. Yoshioka M, Ichiguchi O. Selection of sublobar resection for C-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET. Ann. Thorac. Cardiovasc. Surg. 2009; 15; 82-88.
39. Wisnivesky JP, Henschke CI, Swanson S et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann. Surg. 2010; 251; 550-554.
40. Motoi N, Hamanaka W, Oba T et al. Evaluation of histologic accuracy on diagnosis and invasion of small-sized lung cancer using intra-operative frozen section. J. Thorac. Oncol. 2011; 6; S566.
41. Solis LM, Behrens C, Raso MG et al. Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer 2012; 118; 2889-2899.
42. Warth A, Stenzinger A, von Brünneck A-C et al. Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur. Respir. J. 2012; 40; 1221-1227.
43. Thunnissen E, Beasley MB, Borczuk AC et al. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study. Mod. Pathol. 2012; 25; 1574-1583.
44. Walts AE, Marchevsky AM. Root cause analysis of problems in the frozen section diagnosis of in situ, minimally invasive, and invasive adenocarcinoma of the lung. Arch. Pathol. Lab. Med. 2012; 136; 1515-1521.
45. Xu L, Tavora F, Battafarano R, Burke A. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am. J. Surg. Pathol. 2012; 36; 273-282.
46. Kadota K, Villena-Vargas J, Yoshizawa A et al. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease. Am. J. Surg. Pathol. 2014; 38; 448-460.
47. Kilicgun A, Turna A, Sayar A, Solak O, Urer N, Gurses A. Very important histopathological factors in patients with resected non-small cell lung cancer: necrosis and perineural invasion. Thorac. Cardiovasc. Surg. 2010; 58; 93-97.
48. Schuchert MJ, Schumacher L, Kilic A et al. Impact of angiolymphatic and pleural invasion on surgical outcomes for stage I non-small cell lung cancer. Ann. Thorac. Surg. 2011; 91; 1059-1065 discussion 1065.
49. Koike T, Yoshiya K, Tsuchida M, Toyabe S. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2013; 146; 372-378.